Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)
China · Delayed Price · Currency is CNY 35.71
+0.51 (1.45%)
Aug 1, 2025, 2:45 PM CST
Beijing Kawin Technology Share-Holding Company Description
Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China.
The company’s products include recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon Alfacon-2 Injection; and compound glycyrrhizin tablets, capsules, and injections, as well as pirfenidone tablets.
The company was founded in 2008 and is based in Beijing, China.
Beijing Kawin Technology Share-Holding Co., Ltd.
| Country | China |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 600 |
| CEO | Desheng Zhou |
Contact Details
Address: Building 3, No. 6, Rongjing East Street Beijing, 100176 China | |
| Phone | 86 10 6789 2271 |
| Website | kawin.com.cn |
Stock Details
| Ticker Symbol | 688687 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000054C3 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Desheng Zhou | President and Chairman of the Board |
| Chongfei He | Vice President, Secretary to the Board and Chief Financial Officer |
| Huan Wang | Executive Vice President and Director |
| Jifeng Shi | Vice President, Chief Research Officer, Core Technical Personnel and Director |
| Shan Liu | Head of Antibody Drug Development Department and Core Technical Personnel |
| Xiang Li | Manager of Information Strategy Research Department and Core Technical Personnel |
| Zhenqiang Du | Vice President |
| Lu Yang | Deputy GM of Beiyi Protein Drug Research & Development and Core Technical Personnel |
| Jian Tang | Vice President |
| Xiao Xu | Vice President |